Good News, Schicksalsschläge oder auch Gossip – in unserem Ticker berichtet die Redaktion über die lustigsten, emotionalsten ...

Multiple clinical trials have shown that GLP-1s are safe and effective for patients with obesity, diabetes and cardiovascular ...

Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the ...

Amazon is launching a new GLP-1 program through One Medical and Amazon Pharmacy to streamline access to popular weight-loss drugs.

Please provide your email address to receive an email when new articles are posted on . Adults with type 2 diabetes had a similar risk for kidney cancer if they used a GLP-1 compared with an SGLT2 ...

Through Amazon Pharmacy, patients will be able to access medications including Novo Nordisk's Wegovy as well as newer oral GLP-1 options.

The financial impact of rising GLP-1 usage extends far beyond Big Pharma. For users of weight-loss drugs, costs can snowball, with bills for supplements, trainers, and clothing piling up. Here are ...

Use of GLP-1 receptor agonists continues to shift rapidly, with early April developments highlighting changes in pricing models, drug access, regulatory oversight and personalized care. Novo Nordisk ...

If you watched the Super Bowl in 2026, you likely saw Serena Williams share her weight loss journey on GLP-1 medications in a commercial. Like millions of others around the country, if you’ve ever ...

Researchers at Toronto's Sinai Health have found that semaglutide—the active ingredient in popular weight loss drugs that mimic the gut hormone GLP-1—acts directly on a subset of liver cells to ...

Inside the Beverly Grove clinic that helps guide and support Angelenos using GLp-1s like Ozempic, Wegovy and Zepbound.

Patches marketed as ‘GLP-1 patches’ actually do not contain GLP-1 active ingredients, such as semaglutide or tirzepatide. Currently, no ‘GLP-1 patches’ are approved by the Food and Drug Administration ...